Stephenson Harwood-Led Tech Investor Targets £100M IPO
Medical technology investor Conviction Life Sciences said on Friday that it is aiming to raise £100 million ($120 million) with a London Stock Exchange listing being advised on by Stephenson Harwood...To view the full article, register now.
Already a subscriber? Click here to view full article